Next Article in Journal
Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade
Next Article in Special Issue
How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles
Previous Article in Journal
The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
Previous Article in Special Issue
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
 
 
Article

Article Versions Notes

Cancers 2022, 14(24), 6136; https://doi.org/10.3390/cancers14246136
Action Date Notes Link
article html file updated 3 September 2025 15:14 CEST Update https://www.mdpi.com/2072-6694/14/24/6136/html
article html file updated 4 March 2023 21:24 CET Update -
article html file updated 1 March 2023 04:02 CET Update -
article html file updated 13 December 2022 14:55 CET Original file -
article supplementary file uploaded. 13 December 2022 14:54 CET - https://www.mdpi.com/2072-6694/14/24/6136#supplementary
article pdf uploaded. 13 December 2022 14:54 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6136/pdf
article xml uploaded. 13 December 2022 14:54 CET Update https://www.mdpi.com/2072-6694/14/24/6136/xml
article xml file uploaded 13 December 2022 14:54 CET Original file -
Back to TopTop